Cellares Bolsters Partnership with Bristol Myers Squibb, Expands Cell Therapy Manufacturing

Cellares has expanded its partnership deal with Bristol Myers Squibb to assist in developing another CAR-T cell therapy using its cell therapy manufacturing platform, Cell Shuttle. The company is also planning for long-term expansion, including new collaborations and builds in the US, Europe, and Asia, as there has been significant interest from pharmaceutical companies looking to partner.